Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating…
<!-- Name:DistributionId Value:8796405 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Monopar
Monopar to Present at Roth Inaugural Healthcare Opportunities Conference
WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics…
Monopar to Present at the H.C. Wainwright BioConnect Conference
WILMETTE, Ill., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics…